Evidence map›Paper›PMID 30516132›Full record

ArticleParasite (Paris, France)2018

Treatment of canine sarcoptic mange with afoxolaner (NexGard

Verena Hampel, Martin Knaus, Jürgen Schäfer, Frederic Beugnet, Steffen Rehbein

Open access · goldAbstract readClinical Trial, VeterinaryMulticenter Study
In one paragraph

Article in Parasite (Paris, France), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Efficacy of a single-dose topical formulation combining Fipronil, Moxidectin and Praziquantel against natural infestations of Notoedres cati, Otodectes cynotis and Felicola subrostratus in cats.Revista brasileira de parasitologia veterinaria = Brazilian journal of veterinary parasitology : Orgao Oficial do Colegio Brasileiro de Parasitologia Veterinaria · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Isoxazolines for treating canine demodicosis, sarcoptic mange (scabies), and lice infestation.The Canadian veterinary journal = La revue veterinaire canadienne · 2022
    Article
  8. Article
  9. Zoonotic Episodes of Scabies: A Global Overview.Pathogens (Basel, Switzerland) · 2022
    Review
  10. Efficacy ofVeterinary world · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Efficacy of afoxolaner plus milbemycin oxime and afoxolaner alone as treatment for sarcoptic mange in naturally infested dogs.Canadian journal of veterinary research = Revue canadienne de recherche veterinaire · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Verena HampelConreso GmbH, 80331 Munich, Germany.
Martin KnausBoehringer Ingelheim Vetmedica GmbH, Kathrinenhof Research Center, 83101 Rohrdorf, Germany.
Jürgen SchäferConreso GmbH, 80331 Munich, Germany.
Frederic BeugnetBoehringer Ingelheim Animal Health 69007 Lyon, France.
Steffen RehbeinBoehringer Ingelheim Vetmedica GmbH, Kathrinenhof Research Center, 83101 Rohrdorf, Germany.
Boehringer Ingelheim (Germany) · DEBoehringer Ingelheim (France) · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The efficacy of NexGard

Indexed as

AcaricidesAnimalsDog DiseasesDogsFemaleGermanyIsoxazolesMacrolidesMaleNaphthalenesPortugalRandom AllocationScabiesTabletsTreatment OutcomeAcaricidesafoxolanerIsoxazolesMacrolidesmilbemycin oximeNaphthalenesTablets

Identifiers

PMID30516132
PMCPMC6280674
OpenAlexW2903357532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.